What is Rho?
Rho operates as a comprehensive contract research organization, offering a full spectrum of clinical research services that span the entirety of the drug development process. Situated near Chapel Hill, NC, the company leverages decades of experience to support pharmaceutical and biotechnology firms in bringing new therapies to market. Its long-standing history and integrated service model position it as a key player in facilitating clinical trials and regulatory submissions.
How much funding has Rho raised?
Rho has raised a total of $5M across 1 funding round:
Debt
$5M
Debt (2020): $5M with participation from PPP
Key Investors in Rho
PPP
Public-Private Partnership
What's next for Rho?
The recent major strategic investment signals a pivotal moment for Rho, likely enabling expansion of its service offerings, enhancement of its technological infrastructure, or further penetration into key therapeutic areas. Given its enterprise-level funding context, Rho is poised for accelerated growth, potentially through strategic acquisitions or the development of novel research methodologies. This capital infusion is expected to solidify its competitive advantage and support its mission to advance medical innovation.
See full Rho company page
